Scailyte announces final closing of pre-series A financing

Please login or
register
12.08.2020
Symbolic picture molecule

Scailyte attracted investiere as an additional investor just before closing the pre-series A financing round. In total, the digital health company raised CHF3.7 million.

The pre-series A financing round will allow Scailyte to develop faster their assays in the rapid-emerging single-cell data technology field. The start-up works on discovering ultrasensitive biomarkers and develops in-vitro diagnostics (IVD) using single-cell technologies and their proprietary single-cell data analysis platform ScaiVision. The raised capital will be used to further build upon Scailyte’s biomarker and IVD pipeline and for the development of the first clinical applications using single-cell biomarkers.

The financing round was led by Swisscom Ventures, joined by 4FO ventures, a private investor and HEMEX. In addition investiere has been attracted as investor. “Scailyte has a strong product pipeline. It includes candidates for biomarkers for Endometriosis and CTCL with a market potential of several hundred million Francs for each of these diagnostics. Furthermore, Scailyte enjoys strong support in the medical expert community” says Susanne Schorsch, Investment Manager at investiere.

“We are continuously developing and utilizing our data analytics platform ScaiVision for biomarker discovery from single-cell data” says Peter Nestorov, CEO of Scailyte AG. “The current version covers all aspects of processing, handling and interpreting single-cell proteomics data (mass and flow cytometry), as well as a core functionality for analysing single-cell transcriptomics data. This allows us to accelerate biomedical discovery and enable the next generation of precision diagnostics. With the support of strong partners like Swisscom Ventures, 4FO and HEMEX, we will continue to grow in the fast-emerging single-cell analysis field, enabling various clinical applications of single-cell data “.

(Press release/SK)

0Comments

More news about

Scailyte AG

Company profiles on startup.ch

Scailyte AG

rss